Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 08, 2016 5:55 AM ET

Healthcare Equipment and Supplies

Company Overview of TransMedics, Inc.

Company Overview

TransMedics, Inc., a medical device company, develops and provides portable warm blood perfusion system that allows for living organ transplant. It offers OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in Europe and Australia. TransMedics, Inc. was founded in 1998 and i...

200 Minuteman Road

Suite 302

Andover, MA 01810

United States

Founded in 1998

93 Employees

Phone:

978-552-0900

Fax:

978-685-9562

Key Executives for TransMedics, Inc.

Founder, Chief Executive Officer, President and Director
Age: 47
Chief Financial Officer
Vice President of Operations
Age: 52
Chief Medical Officer
Age: 46
Vice President of Business Development
Compensation as of Fiscal Year 2015.

TransMedics, Inc. Key Developments

TransMedics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 03:00 PM

TransMedics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 03:00 PM. Venue: Westin Grand Central, New York, New York, United States.

TransMedics, Inc. Announces Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT

TransMedics, Inc. announced that the PROCEED II heart transplant Food and Drug Administration pivotal trial results using the Organ Care System - Heart platform were announced on Saturday, April 12, 2014 at the International Society for Heart and Lung Transplantation 34th Annual Meeting and Scientific Sessions in San Diego, Calif. The OCS Heart PROCEED II FDA pivotal trial met its success criteria for both the primary effectiveness and safety endpoints by demonstrating that the OCS is as safe and effective as the current standard of care (SOC) in preserving standard donor hearts for transplantation. These results were achieved despite the OCS arm having significantly longer total cross clamp time as compared to SOC. In addition, the data from PROCEED II Trial demonstrated that circulating lactate level of the OCS perfusion could be a useful parameter to evaluate donor hearts status ex-vivo.

Similar Private Companies By Industry

Company Name Region
Rx Timer Cap, LLC United States
RIK Medical LLC United States
IYIA Technologies, Inc. United States
Boston Medical Technologies, Inc. United States
Sparton Medical Systems Colorado, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 11, 2015
--
Private Placement
May 29, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TransMedics, Inc., please visit www.transmedics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.